The NRF2–Coactivator associated arginine methyltransferase 1 (CARM1) axis epigenetically regulates PPP enzymes in gastric cancer, whereas MYC-dependent NRF2 activation drives similar programs in head and neck tumors [45,46]. This evidence concerns the gene NFE2L2 and head and neck neoplasm.